Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular targets of curcumin in breast cancer (Review)
Xinqiang Song, Mu Zhang, Erqin Dai, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 180-200
Open Access | Times Cited: 44
Curcumin, its derivatives, and their nanoformulations: Revolutionizing cancer treatment
Iftikhar Ahmad, Sameer Ahmad, Ausaf Ahmad, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 18
Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review
Rabia Shabir Ahmad, Muhammad Bilal Hussain, Muhammad Tauseef Sultan, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 121
Obstacles against the Marketing of Curcumin as a Drug
Kambiz Hassanzadeh, Lucia Buccarello, Jessica Dragotto, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6619-6619
Open Access | Times Cited: 110
Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
Reyhaneh Farghadani, Rakesh Naidu
Cancers (2021) Vol. 13, Iss. 14, pp. 3427-3427
Open Access | Times Cited: 91
Dietary Phenolic Compounds as Anticancer Natural Drugs: Recent Update on Molecular Mechanisms and Clinical Trials
Saad Bakrim, Nasreddine El Omari, Naoufal El Hachlafi, et al.
Foods (2022) Vol. 11, Iss. 21, pp. 3323-3323
Open Access | Times Cited: 53
How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
Yaseen Hussain, Haroon Khan, Ghallab Alotaibi, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4058-4058
Open Access | Times Cited: 41
Curcumin and nanodelivery systems: New directions for targeted therapy and diagnosis of breast cancer
Ruhong Zhou, Jie Gong, Xianguang Deng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117404-117404
Open Access | Times Cited: 13
Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line
Radwa Fawzy, Amal AbdEl-Aziz, Khalid Bassiouny, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100339-100339
Open Access | Times Cited: 10
Potential Applications of the Anti-Inflammatory, Antithrombotic and Antioxidant Health-Promoting Properties of Curcumin: A Critical Review
Elli Rapti, Theodora Adamantidi, Pavlos Efthymiopoulos, et al.
Nutraceuticals (2024) Vol. 4, Iss. 4, pp. 562-595
Open Access | Times Cited: 9
RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells
Reza Mahmoudi, Seyedeh Ashraf Mirahmadi-Babaheidri, Hamdollah Delaviz, et al.
Journal of Biomaterials Applications (2020) Vol. 35, Iss. 7, pp. 743-753
Closed Access | Times Cited: 62
Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance
Fayyaz Ahmed, Bushra Ijaz, Zarnab Ahmad, et al.
Phytomedicine (2020) Vol. 68, pp. 153168-153168
Closed Access | Times Cited: 61
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
Marta C. Nocito, Arianna De Luca, Francesca Prestia, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1476-1476
Open Access | Times Cited: 54
Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities
Rabin Neupane, Sai H. S. Boddu, Mariam Sami Abou-Dahech, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 960-960
Open Access | Times Cited: 52
Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines
Elham Jamshidifar, Faten Eshrati Yeganeh, Mona Shayan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7948-7948
Open Access | Times Cited: 50
In Vivo Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review
Alicia S. Ombredane, Vitória R. P. Silva, Laise Rodrigues de Andrade, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 49
Latest Innovations and Nanotechnologies with Curcumin as a Nature-Inspired Photosensitizer Applied in the Photodynamic Therapy of Cancer
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1562-1562
Open Access | Times Cited: 48
Antitumor Properties of Curcumin in Breast Cancer Based on Preclinical Studies: A Systematic Review
Kênia Alves Barcelos, Carolina Rodrigues Mendonça, Mark A. Noll, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2165-2165
Open Access | Times Cited: 32
Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy
Kyumin Mo, Ayoung Kim, Soohyun Choe, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2065-2065
Open Access | Times Cited: 18
Some important anticancer herbs: A review
Sanket Uttam Mandlik -, Manisha Bhagorao Gayake -, Ashwini R. Nalavade -, et al.
International Journal For Multidisciplinary Research (2023) Vol. 5, Iss. 5
Open Access | Times Cited: 18
Curcumin Administration Routes in Breast Cancer Treatment
B. C. Mayo, Silvana Penroz, Keila Torres, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11492-11492
Open Access | Times Cited: 7
The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management
Andrea Amaroli, Isabella Panfoli, Matteo Bozzo, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2580-2580
Open Access | Times Cited: 6
Resveratrol, Curcumin and Piperine Alter Human Glyoxalase 1 in MCF-7 Breast Cancer Cells
Betina Schmidt, Christian Ferreira, Carlos Luan Alves Passos, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5244-5244
Open Access | Times Cited: 40
In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors
Mohamed E.M. Saeed, Rümeysa Yücer, Mona Dawood, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3966-3966
Open Access | Times Cited: 26
Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions
Bala Mohan Sivani, Mahmoud Azzeh, Rajashree Patnaik, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 639-639
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top